Biolytica

Primary contact
Bahnhofplatz
6300 Zug
Switzerland
+41 (0)41 515 5454
Bahnhofplatz
6300 Zug
Switzerland
+41 (0)41 515 5454
Sections Longevity
Technologies Artificial Intelligence
Funding π°
Key people π§βπ€βπ§
- Dr. Rob Konrad Maciejewski - Co-founder & CEO
- Dan Fobes - Co-founder and VP of Engineering
- James Raaff - Co-founder & Chief Program Officer
- Alexandra Ezhkova - Co-founder & Head of Events
- JΓΆrg Rieker - President of the Board
Highlights β
- Biolytica NEXUS: A B2B offering for health & longevity facilities that enables them to create unique health optimization experiences for their clients. It is said to include everything these facilities need to take patient interactions and customer data management to the next level.
- Biolytica AIME: A set of B2C concierge longevity programs that are tailored specifically to every user's unique biological characteristics, genetic data, and lifestyle factors.
- Growing market: According to Allied Market Research, the global longevity and anti-senescence therapy market was valued at $25.1 billion in 2020 and is projected to reach $44.2 billion by 2030, growing at a CAGR of 6.1% from 2021 to 2030. π
In the news π°
Quotes π¬
“
The team at Biolytica is at the forefront of hyper-personalized health, data analytics and lifespan extension. We are confident that their unique approach to science-based, data-driven and AI supported healthcare will have a transformative impact not only on the longevity industry, but on healthcare and prevention in general.
— Joerg Rieker, Founding Partner at Maximon and Board Member of Biolytica π
Last update: May 9, 2023
Disclaimer: We can not guarantee that the information on this page is 100% correct. more